METHOD FOR IMMOBILIZING A PROTEIN ON SELF-ASSEMBLED MONOLAYER

Information

  • Patent Application
  • 20130203185
  • Publication Number
    20130203185
  • Date Filed
    March 14, 2013
    11 years ago
  • Date Published
    August 08, 2013
    10 years ago
Abstract
One molecule of the amino acid selected from the five kinds of amino acids consisting of cysteine, lysine, histidine, phenylalanine, and glycine is interposed between a self-assembled monolayer and a molecule of a protein. A method for immobilizing an protein on a self-assembled monolayer includes the following steps (a) and (b) in this order: a step (a) of preparing a substrate including one molecule of an amino acid and the self-assembled monolayer and a step (b) of supplying the protein to the substrate to form a peptide bond represented by a predetermined chemical formula as a result of reaction between the carboxyl group of the one molecular of the amino acid and the amino group of the protein.
Description
BACKGROUND

The present disclosure relates to a method for immobilizing a protein on a self-assembled monolayer.


A biosensor is used to detect or quantify a target substance contained in a sample. Some biosensors include protein capable of binding to the target substance to detect or quantify the target substance. More particularly, a biosensor for detecting or quantifying an antigen includes an antibody capable for binding specifically to the antigen. Similarly, biosensors for detecting or quantifying biotin and glucose include streptavidin and glucose oxidase, respectively.


When a sample containing the target substance is supplied to the biosensor including protein capable of binding to the target substance, the target substance is bound to the protein to detect or quantify the target substance.


International Patent Publication No. WO00/04382 discloses a conventional biosensor including protein. WO00/04382 corresponds to Japanese Publication of a translation of PCT international application No. 2002-520618 (see, e.g. Page 24, lines 23-26, Page 25, lines 3-20, Page 25, line 27-Page 26, line 13, Page 26, lines 14-22, Page 28, lines 21-23, Page 32, lines 3-29, Page 35, and line 21-Page 36, line 21 of WO00/04382 or paragraphs [0080], [0082], [0084], [0085], [0095], [0109], [0118], and [0119] of the corresponding Japanese Publication). FIG. 2 shows a biosensor disclosed in FIG. 7 of Patent Literature 1.


According to the description regarding FIG. 7 of WO00/04382, the biosensor is used for screening an activity of a biomolecule. The biosensor includes a monolayer 7, an affinity tag 8, an adaptor molecule 9, and a protein 10. The monolayer 7 is composed of a self-assembled monolayer represented by chemical formula: X—R—Y (see, Page 24, lines 23-26, Page 25, lines 3-20, Page 25, line 27-Page 26, line 13, and Page 26, lines 14-22 of WO00/04382; or paragraphs [0080], [0082], [0084] and [0085] of the corresponding Japanese Publication). Examples of X, R, and Y are HS—, an alkane, and a carboxyl group, respectively (see, Page 25, lines 3-20, Page 25, lines 27-Page 26, line 13, and Page 28, lines 21-23 of WO00/04382; or paragraphs [0084], [0085], and [0095] of the corresponding Japanese Publication).


BRIEF SUMMARY
Technical Problem

In order to improve the detection sensitivity or the quantification accuracy of the target substance, it is required to increase an amount of protein to be immobilized on the biosensor.


The present inventor has discovered that the amount of the immobilized protein per unit area was increased significantly by binding one molecule amino acid selected from the group consisting of cysteine, lysine, histidine, phenylalanine, and glycine to a self-assembled monolayer and then immobilizing protein. The present subject matter has been provided on the basis of the discovery.


The purpose of the present disclosure is to provide a method for increasing an amount of protein to be immobilized on the self-assembled monolayer, and a sensor with the protein immobilized in accordance with the same method.


Solution to Problem

A method for immobilizing a protein on a self-assembled monolayer includes the following steps. Step (a) is a step of preparing a substrate including one molecule of an amino acid and the self-assembled monolayer. The one molecule of the amino acid is bound to the self-assembled monolayer through a peptide bond represented by the following chemical formula (I):




embedded image


where R represents the side chain of one molecule of the amino acid. The one molecular of the amino acid is selected from the five kinds of amino acids consisting of cysteine, lysine, histidine, phenylalanine, and glycine. Step (b) is a step of supplying the protein to the substrate to form a peptide bond represented by the following chemical formula (II) as a result of reaction between the carboxyl group of the one molecule of the amino acid and the amino group of the protein:




embedded image


where R represents the side chain of the one molecule of the amino acid.


In one embodiment, the step (a) may include the following steps (a1) and (a2). Step (a1) is a step of preparing the substrate comprising the self-assembled monolayer on the surface thereof, the self-assembled monolayer having a carboxyl acid at one end. Step (a2) is a step of supplying the one molecule of the amino acid to form the peptide bond represented by the chemical formula (I) as a result of reaction between the carboxyl group of the one end of the self-assembled monolayer and the amino group of the one molecule of the amino acid.


In one embodiment, the method may further include, between the step (a) and the step (b), a step (ab) of activating the carboxyl group of the one molecule of the amino acid with a mixture of N-Hydroxysuccinimide and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride.


In one embodiment, the method may further includes, between the step (a1) and the step (a2), a step (a1a) of activating the carboxyl group of the self-assembled monolayer with a mixture of N-Hydroxysuccinimide and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride.


In one embodiment, the chemical formula (II) may be represented by the following chemical formula (III):




embedded image


where R represents the side chain of the one molecule of the amino acid.


One aspect of the present disclosure is a sensor including a self-assembled monolayer, one molecule of an amino acid, and a protein. The one molecule of the amino acid is interposed between the self-assembled monolayer and the protein, and the protein is bound to the self-assembled monolayer through two peptide bonds represented by the following chemical formula (II):




embedded image


where R represents the side chain of the one molecule of the amino acid. The one molecule of the amino acid is selected from the five kinds of amino acids consisting of cysteine, lysine, histidine, phenylalanine, and glycine.


In one embodiment, the chemical formula (II) may be represented by the following chemical formula (III):




embedded image


where R represents the side chain of the one molecule of the amino acid.


One aspect of the present disclosure is a method for detecting or quantifying a target substance contained in a sample with use of a sensor. The method includes the following steps. Step (a) is a step of preparing the sensor including a self-assembled monolayer, one molecule of an amino acid, and a protein. The one molecule of the amino acid is interposed between the self-assembled monolayer and the protein, and the protein is bound to the self-assembled monolayer through two peptide bonds represented by the following chemical formula (II):




embedded image


where R represents the side chain of the one molecule of the amino acid. The one molecule of the amino acid is selected from the five kinds of amino acids consisting of cysteine, lysine, histidine, phenylalanine, and glycine. Step (b) is a step of supplying the sample to the sensor to bind the target substance to the protein. Step (c) is a step of detecting the target substance bound in the step (b), or quantifying the target substance contained in the sample from the amount of the target substance bound in the step (b).


In one embodiment, the chemical formula (II) may be represented by the following chemical formula (III):




embedded image


where R represents the side chain of the one molecule of the amino acid.


Advantageous Effect

The present subject matter can increase significantly the amount of the protein to be immobilized per unit area.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows an exemplary schematic view of a method according to one embodiment of the present disclosure.



FIG. 2 corresponds to FIG. 7 of WO00/04382.



FIG. 3 shows a schematic view of a method according to the prior art.





DETAILED DESCRIPTION

The embodiment of the present disclosure is described below with reference to FIG. 1.



FIG. 1 shows an exemplary method according to the present disclosure for immobilizing protein on a self-assembled monolayer.


Preferably, a substrate 1 is a gold substrate. An example of the gold substrate is a substrate having gold uniformly on its surface. Specifically, the gold substrate may be a substrate having a gold film formed by a sputtering method on the surface of glass, plastic, or SiO2.


First, the substrate 1 is immersed into a solvent containing an alkanethiol. Preferably, the substrate is washed before immersed. The alkanethiol has a carboxyl group at the end thereof. It is preferable that the alkanethiol has the carbon number within the range from six to eighteen. Thus, a self-assembled monolayer 2 is formed on the substrate 1.


The preferred concentration of the alkanethiol is approximately 1 mM to 10 mM. The solvent is not limited to, as long as it dissolves the alkanethiol. An example of the preferred solvent is ethanol, dimethyl sulfoxide (hereinafter, referred to as “DMSO”), and dioxane. The preferred immersing period is approximately 12 to 48 hours.


Next, an amino acid 3 is supplied to the self-assembled monolayer 2. The carboxyl group (—COOH), which is located at the top end of the self-assembled monolayer 2, reacts with an amino group (—NH2) of the amino acid 3 to form a peptide bond represented by the following the chemical formula (I):




embedded image


where R represents the side chain of the one molecule of the amino acid.


In the chemical formula (I), one molecule of the amino acid 3 binds to the self-assembled monolayer 2.


The amino acid 3 is selected from five kinds of amino acids consisting of cysteine, lysine, histidine, phenylalanine, and glycine. In other words, in the chemical formula (I), R is the side chain of these five kinds of amino acids.


When the amino acid 3 is supplied to the self-assembled monolayer 2, two or more kinds of amino acids may be supplied simultaneously. In other words, when a solution containing the amino acid 3 is supplied to the self-assembled monolayer 2, the solution may contain two or more kinds of the amino acids 3. In light of uniform bind of the protein to the amino acid 3, which is described later, it is preferred that the solution contains a sole kind of amino acid.


Subsequently, protein 4 is supplied. The 5′-terminal amino group of the protein 4 reacts with the carboxyl group of the amino acid 3. The amino group of the lysine included in the protein also reacts with the carboxyl group of the amino acid 3. Thus, two peptide bonds represented by the following chemical formula (II) are formed to obtain a sensor:




embedded image


where R represents the side chain of the one molecule of the amino acid.


One molecule of the protein 4 has only one N-terminus (the start of the protein terminated by an amino acid with a free amine group), corresponding to the 5′ end of mRNA encoding the protein, whereas the one molecule of the protein 4 has a lot of lysine groups having a free amine group. Therefore, almost all of the chemical formula (II) is represented more specifically by the following chemical formula (III):




embedded image


where R represents the side chain of the one molecule of the amino acid.


The obtained sensor is used for detecting or quantifying the target substance contained in the sample.


EXAMPLES

The following examples and comparative examples describe the present subject matter in more detail.


Comparative Example A 1

As shown in FIG. 3, Protein A was bound directly with an amide coupling reaction to a carboxyl group located at the top end of self-assembled alkanethiol formed on the gold surface to immobilize the Protein A. The procedure and the results were described below. It is well-known that Protein A is a protein which constitutes five percent of the cell wall of staphylococcus aureus and is abbreviated as “SpA”.


[Preparation of a Sample Solution]

A sample solution of 16-Mercaptohexadecanoic acid with final concentration of 10 mM was prepared. The solvent thereof was ethanol.


[Formation of a Self-Assembled Monolayer]

A gold substrate (available from GE healthcare company, BR-1004-05) with gold vapor-deposited on glass was used as a substrate 1. The substrate 1 was washed for ten minutes with a piranha solution containing concentrated sulfuric acid and 30% hydrogen peroxide water. The volume ratio of the concentrated sulfuric acid to the 30% hydrogen peroxide water contained in the piranha solution was 3:1.


Subsequently, the gold substrate was immersed in the sample solution for 18 hours to form a self-assembled monolayer on the surface of the gold substrate. Finally, the substrate 1 was washed with pure water and dried.


[Immobilization of Protein]

As protein, Protein A was bound to the carboxyl acid group located at the top end of the 16-Mercaptohexadecanoic acid which formed the self-assembled monolayer to immobilize the Protein A.


Specifically, the carboxyl acid group located at the top end of the 16-Mercaptohexadecanoic acid was activated with use of 35 microliters of a mixture of 0.1M NHS (N-Hydroxysuccinimide) and 0.4M EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride). Subsequently, 35 microliters of the Protein A (40 ug/ml) was added at the flow rate of 5 microliters/minute. Thus, the carboxyl acid of the 16-Mercaptohexadecanoic acid was coupled with the amino group of the Protein A.


Example A1

Experiment was conducted similarly to the comparative example A1 except that glycine was supplied as the one molecule of the amino acid between the formation of the self-assembled monolayer and the immobilization of the Protein A. The procedure and the results are described below.


[Immobilization of Amino Acid (Glycine)]

Glycine was bound with the carboxyl group located at the top end of the 16-Mercaptohexadecanoic acid which formed the self-assembled monolayer 2 to immobilize the glycine.


Specifically, after the carboxyl group was activated similarly to the comparative example A1, 35 microliters of 0.1M glycine (pH: 8.9) was added at the flow rate of 5 microliters/minute. Thus, the carboxyl group of 16-Mercaptohexadecanoic acid was coupled with the amino group of the glycine.


[Immobilization of Protein]

Subsequently, Protein A was bound to the carboxyl group of the glycine to immobilize the Protein A. Specifically, after the carboxyl group of the glycine was activated similarly to the above, 35 microliters of Protein A (concentration: 250 micrograms/ml) was added at the flow rate of 5 microliters/minute. Thus, the carboxyl group was coupled with the 5′-terminal amino acid of the Protein A or the amino group of the lysine included in the Protein A.


[Comparison of the Immobilization Amounts]

The immobilization amounts in the example A1 and in the comparative example A1 were measured with use of an SPR device, Biacore 3000 (available from GE healthcare company).


The term “immobilization amount” means the amount of the protein immobilized per unit area.


Comparative Examples A2-A16

Serine, alanine, glutaminic acid, methionine, leucine, valine, threonine, isoleucine, tyrosine, asparagine, tryptophan, aspartic acid, arginine, proline and glutamine were used instead of glycine, and each immobilization amount was measured similarly to the case of the example A1.


Examples A2-A5

Cysteine, lysine, histidine and phenylalanine were used instead of glycine, and each immobilization amount was measured similarly to the case of the example A1.


Table 1 shows the immobilization amounts of Protein A in accordance with the examples A1-A5 and the comparative examples A1-A16.













TABLE 1









Example A2
Cysteine
17.96117



Example A3
Lysine
14.27184



Example A4
Histidine
11.35922



Example A5
Phenylalanine
10.87379



Example A1
Glycine
9.708738



Comparative Example A16
Asparagine
9.223301



Comparative Example A2
Methionine
9.126214



Comparative Example A3
Serine
8.932039



Comparative Example A4
Tyrosine
6.850394



Comparative Example A5
Tryptophan
8.349515



Comparative Example A6
Leucine
7.76699



Comparative Example A7
Glutamine
7.378641



Comparative Example A8
Alanine
7.281553



Comparative Example A9
Isoleucine
5.533981



Comparative Example A10
Threonine
5.242718



Comparative Example A11
Proline
4.07767



Comparative Example A12
Glutamic acid
3.203883



Comparative Example A13
Aspartic acid
2.427184



Comparative Example A14
Valine
2.106796



Comparative Example A15
Argnine
0.621359



Comparative Example A1
(None)
1










Examples B1-B5 and Comparative examples B1-B16

Experiments similar to the example A1-A5 and the comparative examples A1-A16 were conducted except that streptavidin was used instead of Protein A.


Table 2 shows the immobilization amounts of the streptavidin in accordance with the examples B1-B5 and the comparative examples B1-B16.













TABLE 2









Example B2
Lysine
33



Example B3
Histidine
32.2



Example B4
Phenylalanine
28.8



Example B5
Cysteine
26.9



Example B1
Glycine
25.6



Comparative Example B16
Methionine
25.6



Comparative Example B2
Glutamic acid
24.2



Comparative Example B3
Tyrosine
24.1



Comparative Example B4
Alanine
21.8



Comparative Example B5
Serine
20.5



Comparative Example B6
Aspartic acid
19.7



Comparative Example B7
Asparagine
18.6



Comparative Example B8
Leucine
12.9



Comparative Example B9
Tryptophan
12



Comparative Example B10
Threonine
9.1



Comparative Example B11
Isoleucine
6.4



Comparative Example B12
Valine
6.1



Comparative Example B13
Glutamine
3.6



Comparative Example B14
Proline
3.1



Comparative Example B15
Argnine
2.5



Comparative Example B1
(None)
1










Examples C1-C5 and Comparative examples C1-C16

Experiments similar to the example A1-A5 and the comparative examples A1-A16 were conducted except that glucose oxidase was used instead of Protein A.


Table 3 shows the immobilization amounts of the glucose oxidase in accordance with the examples C1-C5 and the comparative examples C1-C16.













TABLE 3









Example C2
Cysteine
37.69685



Example C3
Lysine
36.59207



Example C4
Histidine
36.16066



Example C5
Phenylalanine
30.35305



Example C1
Glycine
30.32874



Comparative Example C16
Methionine
29.62198



Comparative Example C2
Serine
29.40409



Comparative Example C3
Alanine
26.89383



Comparative Example C4
Asparagine
25.171



Comparative Example C5
Leucine
23.02633



Comparative Example C6
Tyrosine
22.1215



Comparative Example C7
Glutamic acid
20.36339



Comparative Example C8
Isoleucine
17.82311



Comparative Example C9
Threonine
15.35175



Comparative Example C10
Aspartic acid
14.48565



Comparative Example C11
Tryptophan
12.91537



Comparative Example C12
Valine
10.40278



Comparative Example C13
Argnine
6.055117



Comparative Example C14
Proline
5.792629



Comparative Example C15
Glutamine
1.202646



Comparative Example C1
(None)
1










Examples D1-D5 and Comparative Examples D1-D16

Experiments similar to the example A1-A5 and the comparative examples A1-A16 were conducted except that antibody was used instead of Protein A.


Table 4 shows the immobilization amounts of the antibody in accordance with the examples D1-D5 and the comparative examples D1-D16.













TABLE 4









Example D2
Histidine
23.86045



Example D3
Cysteine
22.74856



Example D4
Lysine
20.91865



Example D5
Phenylalanine
18.86891



Example D1
Glycine
18.63296



Comparative Example D16
Tryptophan
17.46708



Comparative Example D2
Methionine
16.50562



Comparative Example D3
Serine
16.01948



Comparative Example D4
Asparagine
15.96672



Comparative Example D5
Tyrosine
15.85254



Comparative Example D6
Alanine
15.40134



Comparative Example D7
Glutamic acid
14.41335



Comparative Example D8
Threonine
13.00732



Comparative Example D9
Leucine
8.816629



Comparative Example D10
Valine
5.974514



Comparative Example D11
Isoleucine
5.701262



Comparative Example D12
Aspartic acid
3.676188



Comparative Example D13
Proline
3.276342



Comparative Example D14
Argnine
2.457678



Comparative Example D15
Glutamine
1.171725



Comparative Example D1
(None)
1










Examples E1-E5 and Comparative examples E1-E16

Experiments similar to the example A1-A5 and the comparative examples A1-A16 were conducted except that albumin was used instead of Protein A.


Table 5 shows the immobilization amounts of the antibody in accordance with the examples E1-E5 and the comparative examples E1-E16.













TABLE 5









Example E2
Cysteine
19.49204



Example E3
Lysine
18.39829



Example E4
Histidine
16.81413



Example E5
Phenylalanine
15.16347



Example E1
Glycine
14.39286



Comparative Example E16
Serine
12.94221



Comparative Example E2
Alanine
12.7583



Comparative Example E3
Glutamic acid
11.42908



Comparative Example E4
Methionine
11.05119



Comparative Example E5
Leucine
10.66873



Comparative Example E6
Valine
8.958131



Comparative Example E7
Threonine
8.8923



Comparative Example E8
Isoleucine
8.802846



Comparative Example E9
Tyrosine
8.288947



Comparative Example E10
Asparagine
8.018876



Comparative Example E11
Tryptophan
7.88124



Comparative Example E12
Aspartic acid
6.962646



Comparative Example E13
Argnine
5.856666



Comparative Example E14
Proline
3.829463



Comparative Example E15
Glutamine
3.654396



Comparative Example E1
(None)
1










A skilled person would understand the followings from Table 1 to Table 5.


When the one molecule of the amino acid selected from the five kinds of amino acids consisting of cysteine, lysine, histidine, phenylalanine and glycine is interposed between the self-assembled monolayer and the protein, the immobilization amount of the protein per unit area is increased, compared to the case where the one molecule of the amino acid selected from other fifteen kinds of the amino acid is used or to the case where one molecule of the amino acid is not used.


INDUSTRIAL APPLICABILITY

The present subject matter can increase significantly the amount of the protein to be immobilized per unit area. This improves the sensitivity or the accuracy of the biosensor. The biosensor may be used for an inspection or a diagnosis which requires the detection or the quantification of the target substance contained in the living sample derived from a patient at a clinical practice.


In the present patent application, Protein A, streptavidin, glucose oxidase, antibody and albumin may be excluded from the term “protein” used in the claims.


REFERENTIAL SIGNS LIST




  • 1: Gold substrate


  • 2: Alkanethiol


  • 3: Amino Acid


  • 4: Protein


Claims
  • 1. A method for immobilizing a protein on a self-assembled monolayer, the method comprising: a step (a) of preparing a substrate comprising one molecule of an amino acid and the self-assembled monolayer, whereinthe one molecule of the amino acid is bound to the self-assembled monolayer through a peptide bond represented by the following chemical formula (I):
  • 2. The method according to claim 1, wherein the step (a) comprises: a step (a1) of preparing the substrate comprising the self-assembled monolayer on a surface thereof, the self-assembled monolayer having a carboxyl group at one end; anda step (a2) of supplying the one molecule of the amino acid to form the peptide bond represented by the chemical formula (I) as a result of reaction between the carboxyl group of the one end of the self-assembled monolayer and an amino group of the one molecule of the amino acid.
  • 3. The method according to claim 1, further comprising, between the step (a) and the step (b): a step (ab) of activating a carboxyl group of the one molecule of the amino acid with a mixture of N-Hydroxysuccinimide and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride.
  • 4. The method according to claim 2, further comprising, between the step (a1) and the step (a2): a step (a1a) of activating the carboxyl group of the self-assembled monolayer with a mixture of N-Hydroxysuccinimide and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride.
  • 5. The method according to claim 1, wherein the chemical formula (II) is represented by the following chemical formula (III):
  • 6. A sensor comprising: a self-assembled monolayer;one molecule of an amino acid; anda protein, wherein:the one molecule of the amino acid is interposed between the self-assembled monolayer and the protein,the protein is bound to the self-assembled monolayer through two peptide bonds represented by the following chemical formula (II):
  • 7. The sensor according to claim 6, wherein the chemical formula (II) is represented by the following chemical formula (III):
  • 8. A method for detecting or quantifying a target substance contained in a sample with use of a sensor, the method comprising: a step (a) of preparing the sensor comprising a self-assembled monolayer, one molecule of an amino acid, and a protein, whereinthe one molecule of the amino acid is interposed between the self-assembled monolayer and the protein,the protein is bound to the self-assembled monolayer through two peptide bonds represented by the following chemical formula (II):
  • 9. The method according to claim 8, wherein the chemical formula (II) is represented by the following chemical formula (III):
  • 10. The method according to claim 1, wherein the protein does not include Protein A, streptavidin, glucose oxidase, antibody or albumin.
  • 11. The sensor according to claim 6, wherein the protein does not include Protein A, streptavidin, glucose oxidase, antibody or albumin.
  • 12. The method according to claim 8, wherein the protein does not include Protein A, streptavidin, glucose oxidase, antibody or albumin.
Priority Claims (1)
Number Date Country Kind
2011-151573 Jul 2011 JP national
CROSS-REFERENCE TO RELATED APPLICATIONS

This is a continuation of International application No. PCT/JP2011/007239, with international filling date of Dec. 22, 2011, which claims priority of Japanese Patent Application No. 2011-151573, filed on Jul. 8, 2011, the contents of all of which are hereby incorporated by reference. Further, it is noted that International Patent Publication Nos. WO2011/089903, WO2012/029202, WO2012/053138, WO2012/168988 and WO2013/005269 are commonly owned by the Assignee of the present application.

Continuations (1)
Number Date Country
Parent PCT/JP2011/007239 Dec 2011 US
Child 13829506 US